Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANET: Darunavir/ritonavir Monotherapy in HIV-1
NCT02155101Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Liverpool. Started May 2014; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02155101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02155101.